- Home
- KWR vs ALVO Comparison
KWR vs ALVO Comparison
Compare KWR & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KWR
- ALVO
- Stock Information
- Founded
- KWR 1918
- ALVO 2013
- Country
- KWR United States
- ALVO Luxembourg
- Employees
- KWR N/A
- ALVO N/A
- Industry
- KWR Major Chemicals
- ALVO Biotechnology: Pharmaceutical Preparations
- Sector
- KWR Industrials
- ALVO Health Care
- Exchange
- KWR Nasdaq
- ALVO Nasdaq
- Market Cap
- KWR 3.0B
- ALVO 3.5B
- IPO Year
- KWR 1985
- ALVO N/A
- Fundamental
- Price
- KWR $166.42
- ALVO $12.39
- Analyst Decision
- KWR Strong Buy
- ALVO Buy
- Analyst Count
- KWR 3
- ALVO 1
- Target Price
- KWR $187.33
- ALVO $18.00
- AVG Volume (30 Days)
- KWR 104.0K
- ALVO 89.9K
- Earning Date
- KWR 10-31-2024
- ALVO 11-13-2024
- Dividend Yield
- KWR 1.16%
- ALVO N/A
- EPS Growth
- KWR 647.22
- ALVO N/A
- EPS
- KWR 6.82
- ALVO N/A
- Revenue
- KWR $1,862,709,000.00
- ALVO $393,919,000.00
- Revenue This Year
- KWR N/A
- ALVO $382.28
- Revenue Next Year
- KWR $3.77
- ALVO $50.44
- P/E Ratio
- KWR $24.52
- ALVO N/A
- Revenue Growth
- KWR N/A
- ALVO 517.92
- 52 Week Low
- KWR $151.31
- ALVO $9.00
- 52 Week High
- KWR $221.94
- ALVO $18.00
- Technical
- Relative Strength Index (RSI)
- KWR 52.03
- ALVO 33.54
- Support Level
- KWR $161.03
- ALVO $12.58
- Resistance Level
- KWR $175.83
- ALVO $13.14
- Average True Range (ATR)
- KWR 4.91
- ALVO 0.46
- MACD
- KWR -0.18
- ALVO -0.16
- Stochastic Oscillator
- KWR 38.01
- ALVO 2.48
About KWR Quaker Houghton
Quaker Houghton manufactures and sells a variety of industrial process fluids. The product portfolio of the company includes metal removal fluids, cleaning fluids, corrosion inhibitors, metal drawing and forming fluids, die-cast mold releases, heat treatment and quenchants, metal forging fluids, hydraulic fluids, specialty greases, offshore sub-sea energy control fluids, rolling lubricants, rod and wire drawing fluids and surface treatment chemicals. The geographic segments of the company include America, EMEA, Asia/Pacific, and Global Specialty Businesses. The majority of the revenue is earned from America.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.